Cytox is developing transformational prognostic technology that may contribute to the assessment of an individual's risk of developing
Cytox has raised €2.1M across 1 funding round from 1 investor, most recently a round in Apr 2014. Based in Manchester, UK; founded 2007. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-04-01 | Other | €2.1M |
| Midven |
| View deal → |
